Purchase Order HHSN272201200497P
Award Date 6/1/12
Potential Completion Date 6/26/13
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Certara USA Inc. for the annual provision of the Phoenix WinNonlin software. The $17,556.00 contract has a period of performance ending on July 22, 2025 and is not designated as a set-aside award. Certara USA Inc. is a leading global technology-enabled drug development and drug safety...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Certara USA Inc., a leading provider of biosimulation software and consulting services. The contract, valued at $16,441.10, is for the procurement of software licenses for Certara's proprietary modeling and simulation tools, including Phoenix WinNonlin, Certara Phoenix, CHEMOFFICE, and SEND EXPLORER. These software products enable federal scientists and reviewers to conduct...
- The Department of Health and Human Services' National Institutes of Health has awarded a firm fixed-price purchase order to Certara USA Inc., a leading global drug development and drug safety consultancy, for the provision of Phoenix WinNonlin software licenses. The $12,266.00 contract will enable federal scientists and reviewers to conduct clinical pharmacology, pharmacometric, and regulatory review analyses on data submitted by industry sponsors. Certara has received numerous prime contracts...
- This $11,660 firm fixed-price purchase order contract was awarded to Certara USA Inc. by the National Institutes of Health (NIH) Clinical Center, a civilian agency. The contract is for the procurement of software licenses and subscriptions for Certara's proprietary modeling and simulation tools, which enable federal scientists and reviewers to conduct clinical pharmacology, pharmacometric, and regulatory review analyses on data submitted by industry sponsors. Certara USA Inc. is a leading global...
- The federal contract award, valued at $10,743.00, was issued by the National Cancer Institute (NCI) to Certara USA Inc., a leading global technology-enabled drug development and drug safety consultancy, for the procurement of software licenses. The contract is a firm-fixed price purchase order with no set-aside designation and an ultimate completion date of August 13, 2025. Certara USA Inc. has received numerous prime contract awards from the NCI, Food and Drug Administration (FDA), and National...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,720 purchase order to Certara USA Inc. for the annual renewal of a CHEMOFFICE software license for 15 seats. The contract has a period of performance from July 5, 2023 through July 4, 2024 and utilizes a firm fixed price payment structure. Certara will provide the requested CHEMOFFICE software license to support research activities at the location of...
- <p>This is a $3,995.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Proteome Software Inc., a self-certified small disadvantaged business. The contract is for a software upgrade license and has an ultimate completion date of April 27, 2015. There is no set-aside designation mentioned for this contract.</p>
- This federal contract award is for $20,770 to Certara USA Inc., a leading technology-enabled drug development and drug safety consultancy, to provide small molecules and biologics toxicology consultant support services to the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH). The contract is not set-aside and is a purchase order with a labor hours pricing type. Certara USA Inc. specializes in biosimulation software and consulting services for the...
- The Food and Drug Administration awarded a $169.5K firm fixed-price purchase order to Certara USA Inc. for annual named user server licenses of Phoenix WinNonlin, Phoenix Connect, Phoenix NLME, and unlimited server license for distributed computing. The award was issued on July 30, 2019, with performance to be completed by July 29, 2022, at the contractor's facility in Silver Spring, Maryland. This contract was not set-aside and followed a solicitation posted on July 18, 2019, with award...
- This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $8,550, was awarded to Xmla Consulting on January 19, 2011 for a Report Portal 3.0 Enterprise License. The contract has an ultimate completion date of January 19, 2012 and does not have a set-aside designation. The award represents a licensing agreement for a software...
This is a firm fixed-price purchase order awarded by the National Institutes of Allergy and Infectious Diseases (NIAID) to Pharsight Corporation, a subsidiary of Certara USA Inc. The contract, valued at $3,716.00, does not have a set-aside designation. The award is likely related to NIAID's drug development and evaluation programs, as Certara's software and consulting services support clinical pharmacology, pharmacometric, and regulatory review activities for government agencies. The award may provide Certara's proprietary modeling and simulation tools, such as Phoenix WinNonlin and Certara Phoenix, to NIAID personnel to analyze data submitted by industry sponsors. The contract has a period of performance ending on June 26, 2013.
Generated 11/24/24, 9:02 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 6/1/12 |